HS-10517

· Jiangsu Hansoh Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HS-10517, covering 2023-04-03 to 2023-04-03. Get the full timeline:

Most recent: Clinical Trial Update: Study of HS-10517 in Chinese Adult Participants [Phase 1, Phase 2]